The Valley Desk

NCT02704403 · Interventional trial

Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)

Overall registry status Terminated

Phase 3

Conditions Nonalcoholic Steatohepatitis (NASH) With Fibrosis

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov